Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Rosonabant
Cat. No.:
OB0425LY-158
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Rosonabant is a potent and selective cannabinoid receptor (CB1 receptor) antagonist that regulates appetite and metabolism.
Synonyms:
861151-12-4; 3-(4-Chlorophenyl)-2-(2,4-dichlorophenyl)-N-piperidin-1-yl-3,4-dihydropyrazole-5-carboxamide; 1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-N-1-piperidinyl-; 5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-4,5-dihydro-1H-pyrazole-3-carboxamide
CAS No.:
861151-12-4
Compound CID:
11316914
Formula:
C21H21Cl3N4O
Formula Weight:
451.78
Specification
Target:
Cannabinoid receptor
Pathway:
GPCR/G protein; Neuronal signaling; MAPK/ERK pathway; Stem cell/Wnt
Storage:
Storage at -20°C.
Applications:
Rosonabant can be used to improve the risk of obesity-related cardio-metabolic disease.
